https://www.selleckchem.com/pr....oducts/tj-m2010-5.ht
Thus, loss of CLN3 function in neurons, not storage accumulation, underlies neurologic dysfunction in CLN3 disease. This impliesies that storage clearance may be an inappropriate target for therapy development and an ineffectual biomarker. To evaluate patterns of cannabis use in patients with cutaneous lymphoma (CL), as well as the association between cannabis use and itch specifically. Cross-sectional survey created in partnership with the Cutaneous Lymphoma Foundation (CLF). The online survey was distributed electronically via emai